Status:
COMPLETED
Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis
Lead Sponsor:
Vinmec Research Institute of Stem Cell and Gene Technology
Conditions:
Encephalitis
Meningitis
Eligibility:
All Genders
2-15 years
Phase:
PHASE1
PHASE2
Brief Summary
To evaluate the safety and efficacy of autologous bone marrow-derived mononuclear cell transplantation in-patient with neurological sequelae due to encephalitis or meningitis
Detailed Description
The purpose of this study is to evaluate the safety and effectiveness of autologous bone marrow-derived mononuclear cell in 22 patients with neurological sequelae due to encephalitis or meningitis at ...
Eligibility Criteria
Inclusion
- Neurological sequelae due to encephalitis or meningitis
Exclusion
- Coagulation disorders
- Allergy to anesthetic agents
- Severe health conditions such as cancer, failure of heart, lung, liver or kidney
- Active infections
Key Trial Info
Start Date :
June 16 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04080921
Start Date
June 16 2014
End Date
August 30 2019
Last Update
June 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vinmec Research Institute of Stem Cell and Gene Technology
Hanoi, Vietnam, 100000